Cargando…
The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
The IMI public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) was launched in 2008 with an initial budget of €2 billion. Aiming to accelerate the development of innovative medicines for areas of unmet clinical nee...
Autores principales: | O'Rourke, Diana, Coll-Padrós, Nina, Bradshaw, Angela, Killin, Lewis, Pradier, Laurent, Georges, Jean, Dawoud, Dalia M., Steukers, Lennert, Diaz, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666729/ https://www.ncbi.nlm.nih.gov/pubmed/36408524 http://dx.doi.org/10.3389/fneur.2022.994301 |
Ejemplares similares
-
Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project
por: Hawksworth, Claire, et al.
Publicado: (2023) -
Avoiding fragmentation: The potential of synergistic efforts across the IMI portfolio
por: Díaz, Carlos, et al.
Publicado: (2022) -
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model
por: Bradshaw, Angela, et al.
Publicado: (2023) -
Precision medicine in neurodegeneration: the IHI-PROMINENT project
por: Tate, Ashley, et al.
Publicado: (2023) -
Project portfolio risk management. Bibliometry and collaboration Scientometric domain analysis
por: Micán Rincón, Camilo Andrés, et al.
Publicado: (2023)